Lymphoma, Large-Cell, Anaplastic
"Lymphoma, Large-Cell, Anaplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called "hallmark" cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.
| Descriptor ID |
D017728
|
| MeSH Number(s) |
C04.557.386.480.750.399 C15.604.515.569.480.750.600 C20.683.515.761.480.750.399
|
| Concept/Terms |
Lymphoma, Large-Cell, Anaplastic- Lymphoma, Large-Cell, Anaplastic
- CD30-Positive Anaplastic Large-Cell Lymphoma
- CD30 Positive Anaplastic Large Cell Lymphoma
- Ki-1 Lymphoma
- Ki 1 Lymphoma
- Ki-1 Lymphomas
- Lymphoma, Ki-1
- Lymphomas, Ki-1
- Systemic Anaplastic Large-Cell Lymphoma
- Systemic Anaplastic Large Cell Lymphoma
- Anaplastic Large-Cell Lymphoma
- Anaplastic Large Cell Lymphoma
- Anaplastic Large-Cell Lymphomas
- Large-Cell Lymphoma, Anaplastic
- Large-Cell Lymphomas, Anaplastic
- Lymphoma, Anaplastic Large-Cell
- Lymphomas, Anaplastic Large-Cell
- CD30+ Anaplastic Large-Cell Lymphoma
- CD30+ Anaplastic Large Cell Lymphoma
- Lymphoma, Large-Cell, Ki-1
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Large-Cell, Anaplastic".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Lymphoma, Large-Cell, Anaplastic [C04.557.386.480.750.399]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, T-Cell [C15.604.515.569.480.750]
- Lymphoma, Large-Cell, Anaplastic [C15.604.515.569.480.750.600]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Lymphoma, Large-Cell, Anaplastic [C20.683.515.761.480.750.399]
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Large-Cell, Anaplastic".
This graph shows the total number of publications written about "Lymphoma, Large-Cell, Anaplastic" by people in this website by year, and whether "Lymphoma, Large-Cell, Anaplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 5 | 0 | 5 |
| 2001 | 3 | 1 | 4 |
| 2003 | 3 | 0 | 3 |
| 2004 | 3 | 0 | 3 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 11 | 2 | 13 |
| 2010 | 4 | 1 | 5 |
| 2011 | 1 | 1 | 2 |
| 2012 | 3 | 2 | 5 |
| 2013 | 4 | 0 | 4 |
| 2014 | 8 | 2 | 10 |
| 2015 | 4 | 2 | 6 |
| 2016 | 4 | 1 | 5 |
| 2017 | 10 | 1 | 11 |
| 2018 | 12 | 1 | 13 |
| 2019 | 18 | 0 | 18 |
| 2020 | 14 | 0 | 14 |
| 2021 | 14 | 2 | 16 |
| 2022 | 13 | 1 | 14 |
| 2023 | 10 | 0 | 10 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma, Large-Cell, Anaplastic" by people in Profiles.
-
Clinicopathologic features of primary central nervous system anaplastic large cell lymphoma: a multicenter study identifies age and ALK status as prognostic factors. J Hematop. 2024 Dec; 17(4):215-222.
-
The Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance. Am J Surg Pathol. 2024 Jun 01; 48(6):e43-e64.
-
American Association of Plastic Surgeons Consensus on Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg. 2024 09 01; 154(3):473-483.
-
Incidental Bystander or Essential Culprit: A Systematic Review of Bacterial Significance in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Int J Mol Sci. 2023 Dec 26; 25(1).
-
Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in the United States: A Systematic Review. Aesthet Surg J. 2023 12 14; 44(1):NP32-NP40.
-
Financial Toxicity in Breast Implant-Associated Anaplastic Large Cell Lymphoma. Ann Plast Surg. 2024 Jan 01; 92(1):34-40.
-
Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Updated Report 2012-2020. Plast Reconstr Surg. 2023 10 01; 152(4S):16S-24S.
-
The Ongoing Hunt for the First BIA-ALCL Smooth Case. Aesthet Surg J. 2023 06 14; 43(7):NP593-NP594.
-
DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. Haematologica. 2023 06 01; 108(6):1604-1615.
-
Brentuximab vedotin use in pediatric anaplastic large cell lymphoma. Front Immunol. 2023; 14:1203471.